<?xml version="1.0" encoding="UTF-8"?>
<ref id="B117-ijms-21-07078">
 <label>117.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kononova</surname>
    <given-names>A.A.</given-names>
   </name>
   <name>
    <surname>Sokolova</surname>
    <given-names>A.S.</given-names>
   </name>
   <name>
    <surname>Cheresiz</surname>
    <given-names>S.V.</given-names>
   </name>
   <name>
    <surname>Yarovaya</surname>
    <given-names>O.I.</given-names>
   </name>
   <name>
    <surname>Nikitina</surname>
    <given-names>R.A.</given-names>
   </name>
   <name>
    <surname>Chepurnov</surname>
    <given-names>A.A.</given-names>
   </name>
   <name>
    <surname>Pokrovskya</surname>
    <given-names>A.G.</given-names>
   </name>
   <name>
    <surname>Salakhutdinov</surname>
    <given-names>N.F.</given-names>
   </name>
  </person-group>
  <article-title>
   <italic>N</italic>-Heterocyclic borneol derivatives as inhibitors of Marburg virus glycoprotein-mediated VSIV pseudotype entry
  </article-title>
  <source>Med. Chem. Commun.</source>
  <year>2017</year>
  <volume>8</volume>
  <fpage>2233</fpage>
  <lpage>2237</lpage>
  <pub-id pub-id-type="doi">10.1039/c7md00424a</pub-id>
 </element-citation>
</ref>
